Clobazam: Difference between revisions
| Line 102: | Line 102: | ||
*hallucinations, inappropriate behavior | *hallucinations, inappropriate behavior | ||
*twitches and tremor | *twitches and tremor | ||
==Pharmacokinetics== | |||
{|class="wikitable" | |||
!style="text-align: left"| Oral bioavailability | |||
|Clonazepam is well absorbed after oral doses. | |||
|- | |||
!style="text-align: left"| Onset of action | |||
|Peak plasma concentrations occur within 1 to 4 hours of a dose. | |||
|- | |||
!style="text-align: left"| Metabolism | |||
|Clonazepam is metabolized in the liver | |||
|- | |||
!style="text-align: left"| Elimination half-life | |||
|Clonazepam is eliminated in the urine. | |||
Its elimination half-life ranges from about 20 to 40 hours, and occasionally more. | |||
|} | |||
Revision as of 02:23, 6 October 2020
Pronunciation
Clobazam 10mg
Introduction
Clobazam is a long-acting benzodiazepine with antiepileptic properties. It may be used as an adjunct with other antiepileptics in the treatment of epilepsy including seizzures associated with the Lennox-Gastaut syndrome, although its use may be limited by the development of tolerance or sedation. It is also used in the short-term treatment of acute anxiety.
Mechanism of Action
- Clobazam is a benzodiazepine.
- Gama-Aminobutyric acid (GABA) is an inhibitory neurotransmitter, acting on the GABA receptors in the central nervous system (CNS), thus inhibiting the nerve impulses.
- It acts on the benzodiazepine receptors in the brain and the spinal cord. Benzodiazepine receptors in the CNS are linked with GABA receptors as a complex.
- Clobazam by binding to the benzodiazepine receptors results in activation of the GABA-benzodiazepine receptor complex, resulting in inhibition of nerve impulses, overall depression of brain and spinal cord.
- Thus Clobazam use helps to promote muscle relaxation, reduce anxiety, control of convulsions and promote sleep.
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Clobazam Tablet 10 mg | CLOB01 | P1S1S3 & Part 1 Dangerous Drug |
| Alprazolam Tablet 0.5 mg | ALPR02 | DDA |
Dosage
| Epilepsy and myoclonus | By mouth
ADULT:
ELDERLY:
ADMINISTRATION IN CHILDREN: The following usual maintenance doses according to age:
|
|---|
Side Effects
Sedative drugs, including alprazolam, have been associated with an increased risk of death.
Possible side effects include:
| Very common (>10% of incidence)
or Common (1-10% of incidence) |
|
|---|---|
| Infrequent(0.1 -1% of incidence) |
|
| Rare (<0.1% of incidence) |
|
Overdosage can produce CNS depression and coma.
Paradoxical reactions
Although unusual, the following paradoxical reactions have been shown to occur:
- aggression, rage
- mania, agitation, and restlessness
- hallucinations, inappropriate behavior
- twitches and tremor
Pharmacokinetics
| Oral bioavailability | Clonazepam is well absorbed after oral doses. |
|---|---|
| Onset of action | Peak plasma concentrations occur within 1 to 4 hours of a dose. |
| Metabolism | Clonazepam is metabolized in the liver |
| Elimination half-life | Clonazepam is eliminated in the urine.
Its elimination half-life ranges from about 20 to 40 hours, and occasionally more. |
